In the North American medical devices industry, there were 17 private equity deals announced in Q2 2023, worth a total value of $2.3bn, according to GlobalData’s Deals Database. The $2.1bn institutional buy-out (ibo) oneoncology by AmerisourceBergen and TPG Capital was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in North America increased by 959% in Q2 2023 compared with the previous quarter’s total of $217.1m and rose by 67% as compared to Q2 2022. Related deal volume increased by 13% in Q2 2023 versus the previous quarter and was 6% higher than in Q2 2022.
The top-ranked financial advisors supporting these private equity deals in North America in Q2 2023 were Piper Sandler Companies; Guggenheim Partners; Harris Williams with 3, 1, 1 deals respectively.
The top-ranked legal advisors supporting these private equity deals in North America Q2 2023 were Morgan, Lewis & Bockius; Ropes & Gray; Wilson Sonsini Goodrich & Rosati Professional with 2, 2, 2 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.